U.S. FDA classifies Aurobindo arm’s formulation unit Official Action Indicated (OAI)
The United States Food and Drug Administration (U.S. FDA) has issued an Official Action Indicated (OAI) classification to Aurobindo Pharma subsidiary Eugia Pharma Specialities’ formulation manufact...
Source: The Hindu
The United States Food and Drug Administration (U.S. FDA) has issued an Official Action Indicated (OAI) classification to Aurobindo Pharma subsidiary Eugia Pharma Specialities’ formulation manufacturing facility near Hyderabad.
